Cite
HARVARD Citation
Murphy, J. et al. (n.d.). ENVISION: A phase 3b/4 randomized, double‐blind, placebo‐controlled, parallel‐group study to verify the clinical benefit of aducanumab in participants with early Alzheimer's disease. Alzheimer's & dementia. p. n/a. [Online].